In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCVS drug price overhaul 'will likely be phased in over several years', says Gabelli's Jeff JonasJeff Jonas, Gabelli Funds Portfolio Manager, joins 'Closing Bell Overtime' to talk CVS overhauling drug pricing, investing opportunity in the healthcare sector and more.
Persons:
Jeff Jonas Jeff Jonas